A new analysis of health records reports that people using glucosamine have a higher likelihood of progressing from mild cognitive impairment (MCI) to dementia. The study associates glucosamine use with about a 25% increase in the probability of this progression among individuals with early cognitive problems.
The research is described as observational, meaning it can identify a correlation but does not prove glucosamine causes harm. The authors also report laboratory findings that suggest glucosamine may intensify a sugar-tagging process in the Alzheimer’s brain, potentially influencing disease progression. However, the outlets emphasize that further clinical trials are needed to determine whether glucosamine directly contributes to faster decline in humans and to clarify the size and relevance of any effect.
Overall, the coverage highlights both the potential signal from real-world data and the preliminary nature of the biological mechanism. It also notes the need for stronger evidence before drawing conclusions about causation or advising changes for all users.
